Publications by authors named "Chiara Bravetti"

Claim this Profile
P
Patients on treatment with risdiplam in Italy: challenges in the interpretation of the real-world data.
Emilio Albamonte, Adrea Lizio, Giorgia Coratti, Lorenzo Maggi, Elena Pegoraro, Chiara Bravetti

Neurol Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myostatin Levels in SMA Following Disease-Modifying Treatments: A Multi-Center Study.
Fiorella Piemonte, Sara Petrillo, Anna Capasso, Giorgia Coratti, Adele D'Amico, Chiara Bravetti

Ann Clin Transl Neurol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Assessment of 4-Year HFMSE Changes in SMA II and III Patients Treated With Nusinersen.
Giorgia Coratti, Francesca Bovis, Marika Pane, Amy Pasternak, Emilio Albamonte, Chiara Bravetti

Eur J Neurol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Italian validation of the SMA independence scale-upper limb module.
Chiara Bravetti, Giorgia Coratti, Maria Carmela Pera, Giulio Gadaleta, Tiziana Mongini

Eur J Pediatr· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Expression of SMN circ4-2b-3 in SMA I Children Treated with Nusinersen is Associated with Improved Motor Outcomes.
Marika Guerra, Alberto Marini, Vittoria Pagliarini, Consuelo Pitolli, Giorgia Coratti, Chiara Bravetti

Mol Neurobiol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I spinal muscular atrophy and disease modifying treatments: a nationwide study in children born since 2016.
Maria Carmela Pera, Giorgia Coratti, Marika Pane, Riccardo Masson, Valeria Ada Sansone, Chiara Bravetti

EClinicalMedicine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for tube feeding in type I SMA patients treated with disease-modifying therapies: a cohort study.
Marika Pane, Giulia Stanca, Giorgia Coratti, Adele D' Amico, Valeria Ada Sansone, Chiara Bravetti

Eur J Pediatr· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasound-assisted and landmark-based nusinersen delivery in spinal muscular atrophy adults: A retrospective analysis.
Bruno Antonio Zanfini, Agata Katia Patanella, Francesco Vassalli, Stefano Catarci, Marika Pane, Chiara Bravetti

Australas J Ultrasound Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome?
Marika Pane, Giulia Stanca, Chiara Ticci, Costanza Cutrona, Roberto De Sanctis, Chiara Bravetti

Eur J Pediatr· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I spinal muscular atrophy patients treated with nusinersen: 4-year follow-up of motor, respiratory and bulbar function.
Marika Pane, Giorgia Coratti, Valeria A Sansone, Sonia Messina, Michela Catteruccia, Chiara Bravetti

Eur J Neurol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caregivers' Expectations on Possible Functional Changes following Disease-Modifying Treatment in Type II and III Spinal Muscular Atrophy: A Comparative Study.
Maria Carmela Pera, Giorgia Coratti, Jacopo Casiraghi, Chiara Bravetti, Alessandro Fedeli

J Clin Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening.
Marika Pane, Maria Alice Donati, Costanza Cutrona, Roberto De Sanctis, Matteo Pirinu, Chiara Bravetti

Eur J Pediatr· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index in type 2 spinal muscular atrophy: a longitudinal study.
Gloria Ferrantini, Giorgia Coratti, Roberta Onesimo, Simona Lucibello, Sarah Bompard, Chiara Bravetti

Eur J Pediatr· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy.
Marika Pane, Giorgia Coratti, Maria Carmela Pera, Valeria A Sansone, Sonia Messina, Chiara Bravetti

Ann Clin Transl Neurol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I SMA "new natural history": long-term data in nusinersen-treated patients.
Marika Pane, Giorgia Coratti, Valeria A Sansone, Sonia Messina, Michela Catteruccia, Chiara Bravetti

Ann Clin Transl Neurol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Development and implementation of pediatric and neonatal nursing information system in an hospital setting: the pediatric PAI].
Antonello Cocchieri, Luca Di Sarra, Fabio D'Agostino, Chiara Bravetti, Marco Pignocco

Ig Sanita Pubbl· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world data.
Marika Pane, Giorgia Coratti, Valeria A Sansone, Sonia Messina, Claudio Bruno, Chiara Bravetti

Ann Neurol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Definition and variables of complexity of nursing care: a literature review].
Chiara Bravetti, Antonello Cocchieri, Fabio D'Agostino, Ercole Vellone, Rosaria Alvaro

Ig Sanita Pubbl· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis